Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 29, 2017

DrugPatentWatch Database Preview

Docetaxel - Generic Drug Details

« Back to Dashboard

What are the generic sources for docetaxel and what is the scope of docetaxel freedom to operate?

is the generic ingredient in three branded drugs marketed by Apotex Inc, Sandoz, Sun Pharma Global, Hospira Inc, Eagle Pharms, Sanofi Aventis Us, Actavis Llc, Pfizer Labs, Jiangsu Hengrui Med, Dfb Oncology Ltd, Teva Pharms Usa, Dr Reddys Labs Ltd, and Accord Hlthcare, and is included in thirteen NDAs. There are three patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Docetaxel has fifteen patent family members in fifteen countries.

There are forty drug master file entries for docetaxel. Fourteen suppliers are listed for this compound.

Summary for Generic Name: docetaxel

Drug Master File Entries: see list40
Suppliers / Packagers: see list14
Bulk Api Vendors: see list59
Clinical Trials: see list667
Patent Applications: see list9,964
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:docetaxel at DailyMed

Pharmacology for Ingredient: docetaxel

Drug ClassMicrotubule Inhibitor
Physiological EffectMicrotubule Inhibition
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eagle Pharms
SOLUTION;IV (INFUSION)205934-001Dec 22, 2015RXNoNo9,308,195► SubscribeY ► Subscribe
Accord Hlthcare
INJECTABLE;INJECTION201195-004Apr 20, 2012APRXYesNo► Subscribe► Subscribe
Hospira Inc
INJECTABLE;INJECTION022234-002Mar 8, 2011APRXYesYes► Subscribe► Subscribe
INJECTABLE;INJECTION201525-001Jun 29, 2011APRXNoNo► Subscribe► Subscribe
Accord Hlthcare
INJECTABLE;INJECTION201195-002Jun 8, 2011RXYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Formulary management
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus